Research Peptide Blend
Glow
Glow is a research blend of three peptides, GHK-Cu, BPC-157 and TB-500, supplied together in one vial. Atlas RND supplies it as a lyophilized peptide blend · 70 mg for laboratory research use only.
Read the 28 published studiesLast updated
For laboratory research use only. The literature below is provided for educational reference by qualified researchers. It is not medical advice, and nothing on this page is a claim about Glow. Not for human or veterinary use.
Published research · 28 studies
Published research on Glow
Peer-reviewed studies grouped by what they investigated, with human clinical trials first, then reviews, then laboratory work. Each links to the original paper.
No published study examines Glow as a blend. The studies below are on each of its components, GHK-Cu, BPC-157 and TB-500, studied on their own.
GHK-Cu research 7 studies
Open the GHK-Cu research page →
Review
BioMed Research International · 2015
Study title: GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
DOI 10.1155/2015/648108 · PMID 26236730
Read the study ↗
Laboratory study
Journal of Cosmetic Dermatology · 2023
Study title: Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests.
DOI 10.1111/jocd.15763 · PMID 37062921
Read the study ↗
Review
Journal of Biomaterials Science, Polymer Edition · 2008
Study title: The human tri-peptide GHK and tissue remodeling.
DOI 10.1163/156856208784909435 · PMID 18644225
Read the study ↗
Review
International Journal of Molecular Sciences · 2018
Study title: Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
DOI 10.3390/ijms19071987 · PMID 29986520
Read the study ↗
Review
Oxidative Medicine and Cellular Longevity · 2012
Study title: The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.
DOI 10.1155/2012/324832 · PMID 22666519
Read the study ↗
Laboratory study
Acta Biomaterialia · 2023
Study title: In situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing.
DOI 10.1016/j.actbio.2023.10.011 · PMID 37832839
Read the study ↗
Laboratory study
Acta Crystallographica Section D: Structural Biology · 2020
Study title: The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography.
DOI 10.1107/S2059798320013741 · PMID 33263328
Read the study ↗
BPC-157 research 13 studies
Open the BPC-157 research page →
Human case series
Alternative Therapies in Health and Medicine · 2021
Study title: Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.
PMID 34324435
Read the study ↗
Human pilot study
Alternative Therapies in Health and Medicine · 2025
Study title: Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.
PMID 40131143
Read the study ↗
Systematic review
HSS Journal · 2025
Study title: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
DOI 10.1177/15563316251355551 · PMID 40756949
Read the study ↗
Review
Sports Medicine · 2026
Study title: Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
DOI 10.1007/s40279-026-02437-0 · PMID 41966639
Read the study ↗
Review
Current Reviews in Musculoskeletal Medicine · 2025
Study title: Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.
DOI 10.1007/s12178-025-09990-7 · PMID 40789979
Read the study ↗
Review
Cell and Tissue Research · 2019
Study title: Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.
DOI 10.1007/s00441-019-03016-8 · PMID 30915550
Read the study ↗
Animal study
Journal of Orthopaedic Research · 2003
Study title: Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.
DOI 10.1016/S0736-0266(03)00110-4 · PMID 14554208
Read the study ↗
Laboratory study
Journal of Applied Physiology · 2011
Study title: The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.
DOI 10.1152/japplphysiol.00945.2010 · PMID 21030672
Read the study ↗
Review
Frontiers in Pharmacology · 2021
Study title: Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.
DOI 10.3389/fphar.2021.627533 · PMID 34267654
Read the study ↗
Review
Gut and Liver · 2020
Study title: Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
DOI 10.5009/gnl18490
Read the study ↗
Laboratory study
Journal of Molecular Medicine · 2017
Study title: Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
DOI 10.1007/s00109-016-1488-y · PMID 27847966
Read the study ↗
Review
Current Neuropharmacology · 2016
Study title: Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.
DOI 10.2174/1570159x13666160502153022 · PMID 27138887
Read the study ↗
Review
Pharmaceuticals · 2025
Study title: Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.
DOI 10.3390/ph18020185 · PMID 40005999
Read the study ↗
TB-500 research 8 studies
Open the TB-500 research page →
Animal study
Journal of Investigative Dermatology · 1999
Study title: Thymosin beta4 accelerates wound healing.
DOI 10.1046/j.1523-1747.1999.00708.x · PMID 10469335
Read the study ↗
Review
Clinical Ophthalmology · 2007
Study title: Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.
PMID 19668473
Read the study ↗
Animal and human study
Cardiovascular Research · 2025
Study title: Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.
DOI 10.1093/cvr/cvaf223 · PMID 41229390
Read the study ↗
Animal study
Nature · 2004
Study title: Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.
DOI 10.1038/nature03000 · PMID 15565145
Read the study ↗
Animal study
Nature · 2007
Study title: Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.
DOI 10.1038/nature05383 · PMID 17108969
Read the study ↗
Review
Sports Medicine · 2026
Study title: Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
DOI 10.1007/s40279-026-02437-0 · PMID 41966639
Read the study ↗
Review
Annals of the New York Academy of Sciences · 2007
Study title: Thymosin beta4: actin regulation and more.
DOI 10.1196/annals.1415.008 · PMID 17947588
Read the study ↗
Laboratory study
Biochemical and Biophysical Research Communications · 2013
Study title: G-actin sequestering protein thymosin-β4 regulates the activity of myocardin-related transcription factor.
DOI 10.1016/j.bbrc.2013.06.069 · PMID 23811404
Read the study ↗
Important research notice. These studies are posted for research reference only. Titles are reproduced exactly as their authors published them and describe what those researchers investigated; they are not claims by Atlas RND about any product. Not for human consumption. All literature is provided for educational reference only and must not be interpreted as medical advice or product claims. Studies of a compound by other groups are not studies of Atlas RND material. By purchasing from Atlas RND you confirm you are a qualified researcher and will use products in accordance with all applicable laws and regulations. Back to the research library →
Molecular profile
TypeLyophilized peptide blend
ComponentsGHK-Cu · BPC-157 · TB-500 (identified by LC-MS on the certificate)
Total peptide mass70 mg
CompositionPLACEHOLDER — per-component masses on the certificate
CertificateCertificate of conformance, per lot
Quality and lot testing
Current lotGLOW-70-224-26
Purity (current lot)99.40%
LaboratoryAxisPharm, LLC
ReportedAug 24, 2026
Certificate of Analysis for lot GLOW-70-224-26 →
Related compounds
Retatrutide · NAD+ · Tirzepatide · Wolverine Stack · BPC-157 · TB-500 · GHK-Cu · DSIP · MOTS-C · Glow product page